Home / Recalls / Healix Infusion Therapy, Inc. / D-1422-2014

D-1422-2014 Class II Terminated

Recalled by Healix Infusion Therapy, Inc. — Sugar Land, TX

Recall Details

Product Type
Drugs
Report Date
July 16, 2014
Initiation Date
February 13, 2014
Termination Date
February 16, 2016
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
10 bags

Product Description

BUPivacaine HCl 0.25% Preservative Free (2.5 mg/mL) 500 mL in On-Q C-bloc (2-14 mL/hr) bag, Healix Infusion Therapy, Inc., 1075 West Park One Drive, Suite 200, Sugar Land, Texas 77478, NDC 75901-7210-53.

Reason for Recall

Presence of Particulate Matter: The bupivacaine HCl injection used to compound this lot of BUPivacaine HCl 0.25% Preservative Free 500 mL in On-Q C-bloc was recalled by the supplier due to a customer complaint of visible particles embedded in the glass vial.

Distribution Pattern

Texas

Code Information

Lot #: 6156-0, Exp 03/07/14

Other recalls by Healix Infusion Therapy, Inc.

  • D-1554-2014 Class II — fentaNYL 2750 mcg/55 mL (50 mcg/mL) in prefilled syringe, COMPOUNDED DRUG, For (June 27, 2014)
  • D-1552-2014 Class II — fentaNYL 2500 mcg/250 mL (10 mcg/mL) in 0.9% Sodium Chloride in flexable bag, CO (June 27, 2014)
  • D-1553-2014 Class II — fentaNYL 200 mcg/100 mL (2 mcg/mL) and Ropivacaine 0.2% in 0.9% Sodium Chloride (June 27, 2014)
  • D-1551-2014 Class II — fentaNYL 1500 mcg/30 mL (50 mcg/mL) in prefilled syringe, COMPOUNDED DRUG For (June 27, 2014)
  • D-1555-2014 Class II — fentaNYL 5000 mcg/250 mL (20 mcg/mL) in 0.9% Sodium Chloride in a flexable bag, (June 27, 2014)